Interpretable machine learning models for the prediction of all-cause mortality and time to death in hemodialysis patients

被引:1
|
作者
Chen, Minjie [1 ]
Zeng, Youbing [2 ]
Liu, Mengting [2 ]
Li, Zhenghui [1 ]
Wu, Jiazhen [3 ]
Tian, Xuan [1 ]
Wang, Yunuo [1 ]
Xu, Yuanwen [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Sch Biomed Engn, Shenzhen, Peoples R China
[3] Shantou Univ, Dept Elect Engn, Shantou, Peoples R China
关键词
hemodialysis; interpretability; machine learning; mortality; prediction models; RANDOM FOREST REGRESSION; CHRONIC KIDNEY-DISEASE; SUDDEN CARDIAC DEATH; VASCULAR ACCESS; RISK; HOSPITALIZATION; COMPLICATIONS; INFECTIONS; RATES;
D O I
10.1111/1744-9987.14212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionThe elevated mortality and hospitalization rates among hemodialysis (HD) patients underscore the necessity for the development of accurate predictive tools. This study developed two models for predicting all-cause mortality and time to death-one using a comprehensive database and another simpler model based on demographic and clinical data without laboratory tests.MethodA retrospective cohort study was conducted from January 2017 to June 2023. Two models were created: Model A with 85 variables and Model B with 22 variables. We assessed the models using random forest (RF), support vector machine, and logistic regression, comparing their performance via the AU-ROC. The RF regression model was used to predict time to death. To identify the most relevant factors for prediction, the Shapley value method was used.ResultsAmong 359 HD patients, the RF model provided the most reliable prediction. The optimized Model A showed an AU-ROC of 0.86 +/- 0.07, a sensitivity of 0.86, and a specificity of 0.75 for predicting all-cause mortality. It also had an R2 of 0.59 for predicting time to death. The optimized Model B had an AU-ROC of 0.80 +/- 0.06, a sensitivity of 0.81, and a specificity of 0.70 for predicting all-cause mortality. In addition, it had an R2 of 0.81 for predicting time to death.ConclusionTwo new interpretable clinical tools have been proposed to predict all-cause mortality and time to death in HD patients using machine learning models. The minimal and readily accessible data on which Model B is based makes it a valuable tool for integrating into clinical decision-making processes.
引用
收藏
页码:220 / 232
页数:13
相关论文
共 50 条
  • [21] Assessment of a serum calcification propensity test for the prediction of all-cause mortality among hemodialysis patients
    Adam M Zawada
    Melanie Wolf
    Abraham Rincon Bello
    Rosa Ramos-Sanchez
    Sara Hurtado Munoz
    Laura Ribera Tello
    Josep Mora-Macia
    M. Amparo Fernández-Robres
    Jordi Soler-Garcia
    Josep Aguilera Jover
    Francesc Moreso
    Stefano Stuard
    Manuela Stauss-Grabo
    Anke Winter
    Bernard Canaud
    BMC Nephrology, 24
  • [22] Prediction of All-Cause Mortality Using an Echocardiography-Based Risk Score in Hemodialysis Patients
    Zhu, Jing
    Tang, Chao
    Ouyang, Han
    Shen, Huaying
    You, Tao
    Hu, Ji
    CARDIORENAL MEDICINE, 2021, 11 (01) : 33 - 43
  • [23] Prediction of all-cause death in hemodialysis patients using elevated postdialysis pulse wave velocity
    Fu, Xiaohong
    Yang, Jihong
    Fan, Zhaoxin
    Chen, Xianguang
    Wu, Jie
    Li, Jie
    Wu, Hua
    CLINICAL NEPHROLOGY, 2016, 85 (02) : 92 - 100
  • [24] Development and validation of an interpretable machine learning for mortality prediction in patients with sepsis
    He, Bihua
    Qiu, Zheng
    FRONTIERS IN ARTIFICIAL INTELLIGENCE, 2024, 7
  • [25] Statins and All-Cause Mortality in Patients Undergoing Hemodialysis
    Jung, Jaehun
    Bae, Gi Hwan
    Kang, Minsun
    Kim, Soo Wan
    Lee, Dae Ho
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2020, 9 (05):
  • [26] Salt Intake and All-Cause Mortality in Hemodialysis Patients
    Ikenoue, Tatsuyoshi
    Koike, Kiyomi
    Fukuma, Shingo
    Ogata, Satoshi
    Iseki, Kunitoshi
    Fukuhara, Shunichi
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 48 (02) : 87 - 95
  • [27] Serum Obestatin: A Biomarker of Cardiovascular and All-Cause Mortality in Hemodialysis Patients
    Beberashvili, Ilia
    Katkov, Anna
    Sinuani, Inna
    Azar, Ada
    Shapiro, Gregory
    Feldman, Leonid
    Gorelik, Oleg
    Stav, Kobi
    Efrati, Shai
    AMERICAN JOURNAL OF NEPHROLOGY, 2018, 47 (04) : 254 - 265
  • [28] Association of serum globulin with all-cause mortality in incident hemodialysis patients
    Pai, Alex Y.
    Sy, John
    Kim, Joseph
    Kleine, Carola-Ellen
    Edward, Jessica
    Hsiung, Jui-Ting
    Kovesdy, Csaba P.
    Kalantar-Zadeh, Kamyar
    Streja, Elani
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 (10) : 1993 - 2003
  • [29] Impact of Transferrin Saturation on All-Cause Mortality in Patients on Maintenance Hemodialysis
    Sato, Madoka
    Hanafusa, Norio
    Tsuchiya, Ken
    Kawaguchi, Hiroshi
    Nitta, Kosaku
    BLOOD PURIFICATION, 2019, 48 (02) : 158 - 166
  • [30] Plasma Cystine Levels and Cardiovascular and All-Cause Mortality in Hemodialysis Patients
    Suzuki, Shota
    Shino, Midori
    Fujikawa, Tetsuya
    Itoh, Yoko
    Ueda, Eiko
    Hashimoto, Tatsuo
    Kuji, Tadashi
    Kobayashi, Naoyuki
    Ohnishi, Toshimasa
    Hirawa, Nobuhito
    Tamura, Kouichi
    Toya, Yoshiyuki
    THERAPEUTIC APHERESIS AND DIALYSIS, 2018, 22 (05) : 476 - 484